A new drug on the market is claimed by its manufacturers to reduce overweight women by 4.55 kg per month with a standard deviation of 0.91 kg. Forty women chosen at random have reported losing an average of 4.05 kg within a month. Does this data Suppose the claim of the manufacturer at 0.05 level of significance? Use the five steps of hypothesis.
1. The following null and alternative hypotheses need to be tested:
"H_0:\\mu=4.55"
"H_a:\\mu\\not=4.55"
This corresponds to a two-tailed test, for which a z-test for one mean, with known population standard deviation will be used.
2. Based on the information provided, the significance level is "\\alpha = 0.05," and the critical value for a two-tailed test is"z_c = 1.96."
The rejection region for this two-tailed test is "R = \\{z: |z| > 1.96\\}."
3. The z-statistic is computed as follows:
4. Since it is observed that "|z| = 3.475 > 1.96=z_c," it is then concluded that the null hypothesis is rejected.
Using the P-value approach:
The p-value is "p=2P(Z<-3.475)=0.000511," and since "p=0.000511<0.05=\\alpha," it is concluded that the null hypothesis is rejected.
5. Therefore, there is enough evidence to claim that the population mean "\\mu"
is different than 4.55, at the "\\alpha = 0.05" significance level.
Comments
Leave a comment